New Cochlear Osia Hearing Implant System
iSpeech.org
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announces today the U.S. Food and Drug Administration (FDA) clearance of the new Cochlear™ Osia® 2 System. The Osia System is the world’s first active osseointegrated steady-state implant (OSI), a new category of bone conduction hearing solutions that uses digital piezoelectric stimulation to bypass damaged areas of the natural hearing system to send sound vibrations directly to the inner ear (cochlea).
To view the multimedia release go to:
https://www.multivu.com/players/English/8453251-cochlear-osia-hearing-implant-system/
Gloss